Upstream Bio is a clinical-stage biotechnology company dedicated to discovering, developing, and commercializing novel targeted therapies for patients suffering from severe inflammatory and respiratory conditions, with a primary clinical focus on illnesses such as severe asthma and chronic rhinosinusitis.